Skip to main content

Medtronic Value Stock - Dividend - Research Selection



Market price date: 08.01.2021
Market price: 119,71 USD

Medtronic Fundamental data and company key figures of the share

Annual reports in USD
Key figures 21-06-2020
Cash flow
Net operating cash flow
Capital Expenditures -
Free cash flow
Balance sheet
Total Equity 50.737.000.000
Liabilities & Shareholders equity 90.689.000.000
Income statement
Net income 4.789.000.000
Eps (diluted) 3,540
Diluted shares outstanding 1.352.820.000
Net sales/revenue 28.913.000.000

Fundamental ratios calculated on: 08-01-2021

Key figures 08-01-2021
Cash flow
P/C 0,00
P/FC 0,00
Balance sheet
Income statement
Div. Yield0,00%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization161.946.075.136,00 USD
IndicesS&P 500
SectorsHealth service
Raw Data SourceUS GAAP in Millionen USD
Stock Split1999-09-27,2.0000/1.0000; 1997-09-15,2.0000/1.0000; 1995-09-29,2.0000/1.0000; 1994-09-30,2.0000/1.0000; 1991-08-30,2.0000/1.0000; 1989-08-31,2.0000/1.0000; 1980-08-01,2.000000/1.000000

Description of the company

Medtronic plc manufactures and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company\'s Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; diagnostics and monitoring devices; mechanical circulatory support, TYRX, and AF products; and remote monitoring and patient-centered software. It also provides transcatheter heart valves, percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment offers surgical care, wound closure, electrosurgical, hernia mechanical device, mesh implant, ablation, interventional lung, ventilator, capnography, airway, sensor, monitor, compression, dialysis, enteral feeding, wound care, and medical surgical products; stapling, vessel sealing, fixation, and hardware instruments; and gastrointestinal, temperature management, inhalation therapy, and renal care solutions.


The company\'s Restorative Therapies Group segment offers products for spine, bone graft substitutes, biologic products, trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis, as well as products to treat conditions of the ear, nose, and throat; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems; and therapies for vasculature in and around the brain. The company\'s Diabetes Group segment offers insulin pumps and consumables, continuous glucose monitoring systems, and Web-based therapy management software.


The company was founded in 1949 and is headquartered in Dublin, Ireland.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,